As of Friday close, Encompass Health Corporation’s (NYSE:EHC) stock was up $0.32, moving up 0.46 percent to $69.50. The average number of shares traded per day over the past five days has been 479,220 shares. 2 times new highs have been achieved over the past 5 days, with a -$1.58 fall in that time frame. In the last twenty days, the average volume was 672,095, while in the previous 50 days, it was 570,920.
Since last month, EHC stock rose 1.39%. Shares of the company fell to $65.18 on 07/27/23, the lowest level in the past month. A 52-week high of $72.06 was reached on 08/15/23 after having rallying from a 52-week low of $45.11. Since the beginning of this year, EHC’s stock price has risen by 16.20% or $9.69, and marked a new high 19 times. However, the stock has declined by -3.56% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
EHC stock investors should be aware that Encompass Health Corporation (EHC) stock had its last reported insider trading activity 2 days ago on Aug 17. Charbonneau Elissa Joy, the Chief Medical Officer of the company, disposed of 8,294 shares for $69.58 on Aug 17. It resulted in a $577,097 divestment by the insider. Tarr Mark J sold 25,330 shares at an average price of $71.06 on Aug 16. The insider now owns 497,405 shares following the transaction. On Feb 10, EVP & Chief Financial Officer COLTHARP DOUGLAS E sold 17,895 shares at $60.78 apiece. The transaction was valued at $1,087,658.
Valuation Metrics
Right now, Encompass Health Corporation (EHC) has a P/E ratio of about 20.97. The stock’s beta is 1.02. Besides these, the trailing price-to-sales (P/S) ratio of 1.51, the price-to-book (PB) ratio of 4.69, and the price-to-cash flow ratio of 60.71 may also be considered.
The latest dividend of $0.15 per share was paid out, remained unchanged from last year’s $0.15. On Wednesday July 20 2022, a $0.13 dividend decrease was announced.
Financial Health
In the three months ended June 29, Encompass Health Corporation’s quick ratio stood at 1.30, while its current ratio was 1.30, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 1.83, and the total debt-to-equity ratio was 1.84. On the profitability front, the trailing twelve-month gross margin is 95.40% percent. In the year ended June 29, EBITDA margin amounted to 20.09%, whereas operating margins totaled 15.10%. Based on annual data, EHC earned $3.72 billion in gross profit and brought in $4.35 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 13.00%. Return on equity (ROE) for the past 12 months was 23.20%.
In Encompass Health Corporation’s quarter-end financial report for June 29, it reported total debt of $2.7 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. EHC’s revenue fell -12.08% to $1.16 billion during the quarter, while net income inched up to $1.19 billion. While analysts expected Encompass Health Corporation to report $0.74 quarterly earnings, the actual figure was $0.95 per share, beating the consensus estimate by 28.40%. During the quarter, the company generated $256.5 million in EBITDA. The liabilities of Encompass Health Corporation were 3.84 billion at the end of its most recent quarter ended June 29, and its total debt was $2.94 billion. The value of shareholders’ equity is $100.23 million.
Technical Picture
This quick technical analysis looks at Encompass Health Corporation’s (EHC) price momentum. With a historical volatility rate of 19.03%, the RSI 9-day stood at 48.98% on 18 August.
With respect to its five-day moving average, the current Encompass Health Corporation price is down by -2.22% percent or -$1.58. At present, EHC shares trade +4.40% above its 20-day simple moving average and +31.60% percent above its 100-day simple moving average. However, the stock is currently trading approximately +10.55% above its SMA50 and +27.66% above its SMA200.
Stochastic coefficient K was 65.72% and Stochastic coefficient D was 75.60%, while ATR was 1.41. Given the Stochastic reading of 60.22% for the 14-day period, the RSI (14) reading has been calculated as 53.34%. As of today, the MACD Oscillator reading stands at -0.86, while the 14-day reading stands at -0.47.
Analyst Ratings
Barclays launched its rating on Encompass Health Corporation (NYSE: EHC) to an Equal weight in a note to investors on March 14, 2023. Encompass Health Corporation (EHC) has been rated Buy by analysts. According to 0 brokerage firms, EHC is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Encompass Health Corporation stock as buy, with 11 recommending it as overweight.
With a median target price of $82.00, the current consensus forecast for the stock is $71.00 – $85.00. Based on these forecasts, analysts predict Encompass Health Corporation (EHC) will achieve an average price target of $80.00.
